1. Opportunities for Small Molecules in Cancer Immunotherapy
   Sabina Y. van der Zanden et al, 2020, Trends in Immunology CrossRef
2. Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression
   Changlin Li et al, 2020, Cellular Oncology CrossRef
3. Immune Therapy Opportunities in Ovarian Cancer
   Lana E. Kandalaft et al, 2020, American Society of Clinical Oncology Educational Book CrossRef
4. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells
   Changjiang Lei et al, 2019, Oncology Letters CrossRef
5. Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect
   Jacopo Junio Valerio Branca et al, 2021, Frontiers in Molecular Biosciences CrossRef
6. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
   Milad Ashrafizadeh et al, 2020, Life Sciences CrossRef
7. Prostate-specific antigen reduction after capecitabine plus oxaliplatin chemotherapy: A case report
   Qian Zou et al, 2023, World Journal of Clinical Cases CrossRef
8. Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth
   Hallie M. Hintz et al, 2021, Cancer Immunology Research CrossRef
9. Translational Learnings in the Development of Chemo-Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
   Hélène Kaplon, 2022, Frontiers in Oncology CrossRef
10. A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
    Sarah Lévesque et al, 2019, OncoImmunology CrossRef
11. Antioxidant and Neuroprotective Effect of a Grape Pomace Extract on Oxaliplatin-Induced Peripheral Neuropathy in Rats: Biochemical, Behavioral and Histopathological Evaluation
    Chryssa Bekiari et al, 2022, Antioxidants CrossRef
12. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
    Anusha Pusuluri et al, 2019, Journal of Controlled Release CrossRef
13. Immunotherapy in Ovarian Cancer: Are We There Yet?
    Lana E. Kandalaft et al, 2019, Journal of Clinical Oncology CrossRef
14. Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition
    Achinto Saha et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef